Stocks and Investing
Stocks and Investing
Tue, June 11, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, June 10, 2013
[ 12:00 AM ] - WOPRAI
Fri, June 7, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 6, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, June 5, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, June 4, 2013
[ 12:00 AM ] - WOPRAI
Mon, June 3, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Peters Upgraded (BMRN) to Strong Buy and Held Target at $75 on, Jun 3rd, 2013
Andrew Peters of Deutsche Bank, Upgraded "BioMarin Pharmaceutical Inc." (BMRN) to Strong Buy and Held Target at $75 on, Jun 3rd, 2013.
Andrew has made no other calls on BMRN in the last 4 months.
There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $70 on, Wednesday, March 20th, 2013
- Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $71 on, Tuesday, February 12th, 2013